BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26857262)

  • 1. Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.
    Li X; Wu WK; Xing R; Wong SH; Liu Y; Fang X; Zhang Y; Wang M; Wang J; Li L; Zhou Y; Tang S; Peng S; Qiu K; Chen L; Chen K; Yang H; Zhang W; Chan MT; Lu Y; Sung JJ; Yu J
    Cancer Res; 2016 Apr; 76(7):1724-32. PubMed ID: 26857262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
    Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
    Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B; Kim JH; Kim M; Kim SY
    World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
    J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
    Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
    Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
    Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
    J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers.
    Lin PC; Yeh YM; Hsu HP; Chan RH; Lin BW; Chen PC; Pan CC; Hsu KF; Hsiao JR; Shan YS; Shen MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression profiling and molecular classification of gastric cancer by the tissue array method.
    Lee HS; Cho SB; Lee HE; Kim MA; Kim JH; Park DJ; Kim JH; Yang HK; Lee BL; Kim WH
    Clin Cancer Res; 2007 Jul; 13(14):4154-63. PubMed ID: 17634543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Han X; Jia X; Sheng C; Li M; Han J; Duan F; Wang K
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102287. PubMed ID: 38253255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.
    Lajus TB; Sales RM
    Gene; 2015 Sep; 568(2):215-9. PubMed ID: 25981591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
    Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
    J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of gastric cancer.
    Zhang YJ; Fang JY
    J Gastroenterol Hepatol; 2008 Jun; 23(6):856-60. PubMed ID: 17854423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing.
    Wong SS; Kim KM; Ting JC; Yu K; Fu J; Liu S; Cristescu R; Nebozhyn M; Gong L; Yue YG; Wang J; Ronghua C; Loboda A; Hardwick J; Liu X; Dai H; Jin JG; Ye XS; Kang SY; Do IG; Park JO; Sohn TS; Reinhard C; Lee J; Kim S; Aggarwal A
    Nat Commun; 2014 Nov; 5():5477. PubMed ID: 25407104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.